Parallax Volatility Advisers’s Immunic IMUX Stock Holding History

Parallax Volatility Advisers’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50	Closed	-$2K	–	3059
2022 Q3	$2K	Buy	+50	New	+$2.09K	﹤0.01%	2959

Other funds holding IMUX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parallax Volatility Advisers's IMUX Position: Q4 2022 in Review

Parallax Volatility Advisers sold out of Immunic (IMUX) in Q4 2022, closing a stake of 5,072 shares — an estimated $160K sold.

Parallax Volatility Advisers first reported a position in IMUX in Q3 2015 and held it in 3 quarters. The position peaked at $160K in Q3 2022. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

Parallax Volatility Advisers reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
Parallax Volatility Advisers sold 5,072 Immunic shares in Q4 2022, an estimated $160K.
Parallax Volatility Advisers first reported a position in Immunic in Q3 2015 and held it in 3 quarters.
Parallax Volatility Advisers's Immunic position peaked at $160K in Q3 2022.
58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Parallax Volatility Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.